Light PharmaLightPharma
Global Pharma ManufacturerQuality Excellence

Analytical Method Lifecycle Management: Ppk Improvement from 0.8 to 1.4

0.8
Ppk before
Marginal capability
1.4
Ppk after
Robust capability achieved
100%
OOS events prevented
Proactive intervention
Multi-site
Expanded to
Broader product portfolio

The Challenge

A pharmaceutical company identified analytical methods with significant variation relative to specifications (Ppk = 0.8) that had not yet caused out-of-specification results but posed growing risk of future OOS events and regulatory citations.

Our Solution

Light Pharma identified execution variations and proposed systematic reduction strategies, implementing method improvements before failures occurred — a proactive approach that protected product quality and avoided costly investigations.

Our Approach

1

Method capability assessment across product portfolio

2

Variation source identification through systematic analysis

3

Method optimization and robustness improvement

4

Expanded deployment across similar methods and sites

Results

0.8
Ppk before
Marginal capability
1.4
Ppk after
Robust capability achieved
100%
OOS events prevented
Proactive intervention
Multi-site
Expanded to
Broader product portfolio

Ready to Achieve Similar Results?

Let's discuss how Light Pharma can help you solve your quality and compliance challenges.